2

,

Microsoft Word - Ｈ22年度雄勝中央病院卒後臨床研修プログラム.docx

3 2 380 32 1 202,812 11,967 17.2 1,441 129 24 1 6 1 3 1 2 3 50-60 /2 2 2 1-2 2 1 2 2 1 1-2 1 CPC / 4 / / 2 / AED ICLS JPTEC 3 a: b: c: d: 4 c,d a b d 70% 2 10 4 11 12 21 7 21 8 5 Evidence Based Medicine

program_japanese

Eng Eng Eng - 40 - Eng Eng - 41 - Eng Eng - 42 - Eng - 43 - Eng - 44 - Eng Eng - 45 - Eng - 46 - - 47 - Eng - 48 - - 49 - - 50 - - 51 - - 52 - - 53 - - 54 - - 55 - - 56 - - 57 - - 58 - - 59 - - 60 - -

2

1 2 17 1884 2 131 1 1..He lived to serve 2 2 2 2 14,416 104,000 1 QOL Quality of Life 2 21 2013 25 21 3 4 5 QOL 6 QOL QOL 59 1 60 7 QOL QOL 8 2,774 2015 27 5 7 241 2015 27 5 8 12 2015 3 7 58 1,030 113

2015電磁波＿歯科医.rtfd

194621 22 50.06 53.96 90.00 28 87.14 85.00 80.00 75.00 70.00 22 53.96 28 80.75 65.00 60.00 55.00 22 50.06 50.00 Quality of Life !! 281026 281026 -6,500-5,500-4,500-3,500-2,500-1,500-500 500 1,500 2,500-6,401-1,281-3,565-2,154-2,265-2,027-1,869-1,657

LUCUA1100＆LUCUA 1周年アニバーサリー！ ～ルクア大阪が発信する新プロジェクト「LIFE」についてのご案内～

発達障害_表01

104 100 60 9,195,336 409 0.004 24 8 31 9,025,983 568 0.006 2012 8 31 6,634,686 956 ( 0.014 ) 2 2011 8 26

25 25 3 5 MMR 1 104 100 60 9,195,336 409 0.004 24 8 31 9,025,983 568 0.006 2012 8 31 6,634,686 956 ( 0.014 ) 2 2011 8 26 2012 8 31 1,032,660 132 ( 0.013 ) 3 2010 6 11 3 11 15.4 1 1 ( ) 12 2 2 3 ER ) (

直売所

1

untitled

障害者職域拡大カリキュラム研究会中間報告書構成案

3 4 5 5 7 7 9 () 9 ()23 34 1 36 47 49 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 ADL QOL 36 37 38 39 40 41 42 43 44 45 46 16 8 () 19 ( ) () 21 () 47 16

[ a] [ ] ( 15) 2005( 17) 2006( 18) [ ( )] [ b] 1996( 8) 1998( 10) 2003( 15) 2006( 18) [ c] [ ] 24

[ a ( :2-4)] [ ( :2-4)] [ ( :2-4)] 1955( 30) 1972( 47) 10 1974( 49) 10 1985() 1996( 8) [ ( :2-4)] 1998( 10) 1992( 4) 2001( 13) 1996( 8) 2000( 12) 23 [ a] [ ] 1993 5 12 3 2003( 15) 2005( 17) 2006( 18) [

untitled

19 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15 19 19 1 17,676 20.0 2 20,970 24.1 3 4,967 23.2 104,10919 4 8,234 18.0 11,428 22.4 1 0 10,954244 17,107 18.7 136 4.8 12,653205 1,239 13.2 10,056686 27,305514

02 2002 02 292,87300 0231 0049.102 40 10 30 80 2008 2010 80 02 12 03 50 93 51 02 40 02 8.27 02 27 0212 2.16 32 1116 Heinz02 03 02 919901 9398 02 0310 16 0 3 5,354 1,330 70 51.2 70 36.9 45.841.8 99 76.9

untitled

230 1985 17 2002 2006 8 2007 9 2010 3 1 2 6,000 3 2007 9 2008 7 2009 7 10 2008 7 2009 7 2009 10 1 2004 4 6 3 2005 77 Medical polis 4 21 2006 3 2004 9 15 2004 2005 2006 2 4 3 1 2 1 60 8 108 100 100 1 100

1

11 10 712 12 10 21 21 1024 Division of Public Health) ()()( )(Ph.D) 21

11 10 712 12 10 21 21 1024 Division of Public Health) ()()( )(Ph.D) 21 1 218 2 3 113 218 13 33039 388 29164 30 4929 28 16 413 16 13 5 24 6 1 2 121317 3 1 2 3 4 () () 30,000 (120235) 430() 1 245 3 11121317

,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,

1 1 1 2 1 3 1 4 2 5 5 6 6 1 6 2 7 3 7 4 7 5 7 7 8 8 10 1 10 2 10 3 10 12 1 12 2 12 3 12 4 13 5 14 14 1 14 1 2 3 4 5 1 2 3 4 16 5 16 6 16 7 17 6 17 18 19~23-19- 1 0.5 1 43.25 2.20 3.60 103.50 43.88 2.20

- 1 - - 2 - - 3 - - 4 - - 5 - - 6 - - 7 - - 8 - - 9 - - 10 - - 11 - - 12 - - 13 - - 14 - - 15 - - 16 - - 17 - - 18 - - 19 - - 20 - - 21 - 6 Qol Quality of Life - 22 - - 23 - - 24 - 7 8 9-25 - 10 Forest

Q E Q T a k Q Q Q T Q =

i 415 q q q q Q E Q T a k Q Q Q T Q = 10 30 j 19 25 22 E 23 R 9 i i V 25 60 1 20 1 18 59R1416R30 3018 1211931 30025R 10T1T 425R 11 50 101233 162 633315 22E1011 10T q 26T10T 12 3030 12 12 24 100 1E20 62

肝臓病教室201207v2配布用.pptx

24 7 28 5 C C C C 11 1 vs 2 vs 1 0 1 600-1000mg 3-5/ 24,48 2448 12 1 1500-2250mg 6-9/ () 1 600-1000mg 3-5/ 0 24 88.1% 0 20 40 60 80 100 C ALT, GPT 30 34.4% ALT, GPT 0 20 40 60 80 100 2 , 2 3 1 1-100% 0

8 8 0

,07,,08, 8 8 0 7 8 7 8 0 0 km 7 80. 78. 00 0 8 70 8 0 8 0 8 7 8 0 0 7 0 0 7 8 0 00 0 0 7 8 7 0 0 8 0 8 7 7 7 0 j 8 80 j 7 8 8 0 0 0 8 8 8 7 0 7 7 0 8 7 7 8 7 7 80 77 7 0 0 0 7 7 0 0 0 7 0 7 8 0 8 8 7

1 5 6 2 3 7 8 4 5 9 10 6 7 11 12 8 1 2 3 4 5 6 7 1989 25.0% 19901999 6 2000 15.0% 9 13 1 2 3 4 5 50 2 5180 45.0% 81 35.0%, 5.0% + +, 5.0% +, 1, 5 +, 3 14 10 0% 20% 40% 60% 80% 100% n=20 3 5 2 n=20 55.0%

LIFE IS 1 eiji asuda MY New Company Profile

7 9 10 11 13 15 16 1 5 6 17 18 19 21 22 LIFE IS 1 eiji asuda MY New Company Profile 2 3 Q1 A 26440 3094,868 2,110 26440 3094,868 2,110 4 A A A A Q2 Q3 Q4 Q5 5 6 QUALITY OF LIFE 7 A + 899 5,895 899 5,895

untitled

5 10% 1 13 15cm 3 4cm 2 RS P Rb Ra S RS Ra Rb P 4 S RS CT MRI Stage 0 Stage I Stage I Stage II Ra Rb P TEM TEM ISR TEM Transanal endoscopic microsurgery 5cm 4cm 5cm TEM 1 2 3 10cm RS 6cm Ra 4cm Rb 2cm

O1C111515001600 2 O1C11 O1C12 O1C13 O1C14 O1C15 O1C16 O1C17 2 1 2 1 1 2 1 1 1 1 1,2 1,2 1 2 1 2 1 1 2 1 2 O1C162016001700 1 2 3 1 1 1 2 2 2 3 1 1 O1C1

1 6 4 8 4 C 2 O1C159001000 1 O1C1 O1C2 O1C3 O1C4 O1C5 1 2 3 1 1 1,2 1 3 3 1,3 1 2 1 1,2 1,2 2 2 2 1,2 1 2 1 2 O1C61010001100 2 O1C6 O1C7 O1C8 O1C9 O1C10 CFS 1 2 1 1 2 2 1 SOPA 1 2 3 1 1 1,2 1 1 1 3 1 2

PISA

A 01 2 015 10 11 12 G 011 2 0111 67

66 A 01 2 015 10 11 12 G 011 2 0111 67 0119 0112 0113 68 0130 0128 0114 0113 0115 0116 0119 69 0111 0128 012 2 0121 1102 0122 0123 0124 70 0125 0126 0126 0111 0127 71 0128 0129 0230 013 0130 0130 011 012

23 24 GDP 25 26 27 28 29 30 31 administration financing decentralization center for research on regional economic systems system system systems systems analysis system analysis CRES 32 regional difference

ネオマファーム施工標準軸組構造

注 1 注 2 注 2 SISI 1. 2. 30 35 40 50 15mm 303 (17kg/) 455 16mm, 18mm 250 (20kg/) 455 303 303 _ 6 455 650 10,465 910 2,730 1,820 1,820 910 2,275 1,365 415 450 650

賃料設定、テナント契約

NIHSS score p NIHSS score p149 4 p g ml 0.8 g ml D 1 D NIH NIHSS 14 D 0.8 g ml

NIHSS score14 1 400 1 p149 1 25 20 NIHSS score14 15 10 5 2 p149 4 p151 0 0.8 g ml 0.8 g ml D 1 D NIH NIHSS 14 D 0.8 g ml 1 2 148 149 3 2 3 A B C 4 D 2 A B C A C 1 Ogata T et al J Neurol Sci 272 83 86 2008

’ÓŠ¹/15/”ł™J

POS POS POS (1)(2) (3) (4) (5) Nursing is science and art. (6) POS Problem Oriented System ND Nursing Diagnosis ICN ICN ANA (7) NANDA (8) ND Nursing Diagnosis CP Collaborative ProblemMP Medical Problem

() CT X X Ver.5 64 ( 3.0 % / 24,, 25 H23 1 Dr 24 24 2 1 25 RI RI ICU 24 25 B 4500 13000 AHA-PALS 5 PALS 24 25 24 25 24 ICU 24 25 24 1 VA VA 25 25 VA HD VA 20 150 () () 25 2 24 25 24 24 414 102 25

本文01id5.indd

1 TFT 9F 906 907 907 1 TFT 9F 906 90 1 P1-01 P1-02 1 1 1 2 1 1 2 P1-03 P1-04 P1-05 4 P1-06 P1-07 P1-08 1 1 1 2 1 2 P1-09 VCM TDM VCM 1 2 2 2 3 3 4 5 1 2 3 4 5 2 P2-01 P2-02 P2-03 83 1 TFT 9F 906 907 906

CE11122_h01-04B

CELEB LIFE TREATMENT MAGAZINE FOR CELEB MEMBERS 2 0 1 1 WINTER For the quality of healthy & sensual life CELEB LIFE TREATMENT MAGAZINE FOR CELEB MEMBERS 2 0 1 1 WINTER For the quality of healthy & sensual

P001-052.indd

Quality of Life 1 TEIJIN CSR Report 2014 2 TEIJIN CSR Report 2014 CONTENTS 3 5 9 15 21 23 25 26 28 37 38 41 42 29 30 34 35 36 43 44 45 49 50 51 52 http://www.teijin.co.jp/csr/ WEB 3 TEIJIN CSR Report 2014

untitled

1 2 3 4 5 6 7 8 9 10 11 12 1 1 13 () 14 15 4 5 6 7 9 10 () 110 110 110 110 11 12 1 2 3 1 1 1 1 1 16 17 A B 18 A B 10 () 19 20 21 22 23 24 25 26 27 28 () 29 30 4 5 6 7 9 10 () 110 110 110 110 11 12 1 2

Digital Photo Professional Ver1.6（Windows）

Windows CT1-5193-000 CANON INC. 2005 J 1 2 3 4 s s s 1 1 s s s s s 1 1 a s s 1 s s 1 2 s a 1 s a 2 3 1 1 s a a 2 a 3 a s s 1 a a s a s s 1 s s 1 2 3 s 1 1 a 2 a 1 a s 2 3 1 1 s a 2 1 3 1 s a 2

2000 3 25-2-

267.indd

(1)...3 (2)...5 (3)...6 (4) (1)...9 (2)...10 (3)...13 (4) 14 (5) (1)...16 (2) (1)...21 (2)...22 (3)

...1...3...3 (1)...3 (2)...5 (3)...6 (4)...7...9 (1)...9 (2)...10 (3)...13 (4) 14 (5)...15...16 (1)...16 (2)...19...21 (1)...21 (2)...22 (3)...24...26...26 (1)...26 (2)...28 (3)...30 (4)...31 (5)...35

untitled

がん診療におけるFDG FDG-PET/CTの役割

PET/CT PET/CT MRI PET PET/CT Kurashiki Central Hospital FDG-PET CT PET/CT (stage1) FDG-PET (stage1) PET/CT FDG-PET PET/CT (stage4) FDG-PET (stage4) PET/CT FDG-PET PET/CT PET/CT

Microsoft Word 年度DPCによるSPECT検査動向に関する報告 _02表紙.doc

DPC SPECT 2 2013 9 DPC/PDPSDiagnosis Procedure Combination / Per-Diem Payment System 1 DPC DRG/PPS: Diagnosis Related Groups / Prospective Payment System 2003 2008 7 2008 DPC 2012 1,500 DPC SPECT 70% DPC

21 1 503604705 MRI CT 1 3 MRIMRS 5 5 5 5 5 6 7 8 17 1 17 2 17 3 17 4 18 5 19 21 1 23 2 1 27 3 2 48 4 3 88 5 105 6 110 7 118 MRS MRS ATP 312CT 65 60 1 2 1 1 1 2 1 2 2 X CT MRS 3 36657269 MRIMRS 1.5TMRSymphony

JFA福島アカデミー2013.indd

QOL 02 QOL QOL UI AI EAThoracotomy TTThoracoscopy TS QOL EA type-c y score UI 3 AI 8 School score QOL score 12

54 1 2018 2 4-1 OK-432 1 15 14 15 US CT MRI 17 cm 0.16 g/kg/day OK-432 3 1 ke 2 2 ke 3 1 1,150 ml 13 US OK-432 4-2 TJ-28 TJ-28 2003 3 2017 6 250 TJ-28 44 16 28 TJ-28 7 2 46 8.5 2 2 9 34 79.1 10 23.3 34

9 13 9 14 9 15 9 16 9 17 9 18 9 19 9 20 9 21 9 22 9 23 9 24 9 25 NPO 9 26

C 11 1 9 12 30 14 00 p.277 289 9 1 9 2 A 9 3 A 9 4 9 5 9 6 9 7 9 8 9 9 PEAP 9 10 9 11 9 12 9 13 9 14 9 15 9 16 9 17 9 18 9 19 9 20 9 21 9 22 9 23 9 24 9 25 NPO 9 26 10 12 30 14 00 p.290 304 10 1 10 2 10

1

1 2 3 2 25 25 29 29 12 12 4 ENG ENG 13 13 3 42 42 60 60 ENG ENG 36 36 14 14 2 26 26 138 138 43 43 55 55 ENG ENG 32 32 14 14 2 27 27 130 130 2,716 2,716 2,812 2,812 2 26 26 2 27 27 297 297 5,528 5,528 25:25

講座の記録

26.1月号indd.indd

健身計画2_04

2006 Konami Sports & Life 1 2 3 2006 Konami Sports & Life 4 5 6 2006 Konami Sports & Life 7 8 9 10 11 12 13 14 15 16 17 18 1 19 2 3 20 4 5 21 6 22 7 23 8 9 10 24 1 2 25 26 1 2 3 4 27 28 1 29 2 30 3 4

untitled

2009/5/8 ICIDH ICIDH ICIDH ICF ICF ICIDH1980, WHO Impairment impairment Disabilityisability disability handicap Handicapandicap ICIDH ICIDH ICIDH 1 ICIDH 1995 1996 1997 1998 1999 2000 2001 London Madrid

1 ---------------------------------------------------------------------------- 1 ------------------------------------------------------------------------- 2 -------------------------------------------------------------------

DSRC普及促進検討会　総会 ＤＳＲＣクレジット決済標準化の検討状況

【HP用】26.12月号indd.indd

26.2月号indd.indd

No.639 334,300 44.7 840,700 885,000 669,700 705,000 631,700 665,000 6 1.40 12 1.55 460,000 2.95 415,000 395,000 172,200 172,200 140,100 140,100 6 1.225 0.645 12 1.375 0.645 2.600 1.290 12 10

untitled

20●12頁●６－１４▲放射線科▲.ppt

No.268 Katayama H. et al. Adverse reactions to ionic and nonionic contrast media-a report from the Japanese Committee of the Safety of Contrast Media. Radiology 1990;175:621-628. 12.66% 3.13% 0.22% 0.04%

10K1A NASA () SPACE ATLAS Freedom H2A NASA 1

10O1A 10 10 1 10K1A NASA () SPACE ATLAS 40 1957 1969 10 1986 1990 Freedom 20 000 H2A NASA 1 10K1A 100 10 21 40 1996 ( 200 () 2 10S1A 10 8 57 250 1 10S1A 20 200mmm 2 10S1B 18 18 1 10S1B 40 10 20 2 10S1C

- October

T1 T2 T3 T4-3- -4- -5- 11 11 12 12 12-6- -7- -8- -9- L 12-10- T T T T -11- 12 T1 T2 T3 T4 14 15 16 10 11 12 1 2 10 40 10 45 10 50 4 11 25 11 35 17 18 19 20 21 2.5cm T1 T2 T3 T4 T5 T6 T7 T8 22 23 24 25

E-mail rsakurai@jade.dti.ne.jp 2000. 2. 1-1-

E-mail rsakurai@jade.dti.ne.jp 2000. 2. 1-1- LD LD LD -2- MBD Minimal Brain Dysfunction Syndrome -3- Minimal Brain Dysfunction Syndrome : --- WISC-WPPSIK-ABC --- CTMRIEEG --- 40 60-4- -5- MBD MBD MBD MBD

TM Reverse Shoulder手術手技書

Zimmer Biomet Trabecular Metal Reverse Shoulder System Surgical Technique 1 Trabecular Metal Reverse Shoulder 22500BZX00475000 Vivacit-E 22700BZX00233000 2 Trabecular Metal Reverse Shoulder TM / / 3 3

原発緊急講演

2011 3 11 2 46 9.0 2011 2 22 11,000 1995 1 17 7.3 350 1923 9 1 45 tsunami 1 6 1 3 4 6 1 3 1,3 2 1 Bq 1 PBq 1000 85 10.7 22PBq 90 28.8 190PBq 95 64 5900PBq 106 372 700PBq 131 8 3100PBq 133 5.24 6300PBq

1 2 3 4 1 3 4 2 5 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 21 24 25 26 27 28 29 30 31 32 33 34 9 35 36 14 9 14 15 37 38 39 35 1 519 4 NPO 40 41 9 10 4 (9 Or10 ) PR 3 21 21 42 2 10 43 44 15

NEDO

10 MRI 1 1 595% 5 IOR 100% MRI MRI MRI MRI MRI MRI 11 MRI 3 2 1 MRI 1 1.5 0.000005 100 5 MRI MRI MRI MRI MRI MRI MRI MRI MRI (1) MRI MRI 0.3 3 MRI 1 / (2) MRI MRI (3)MRI MRI 3 (4)MRI MRI MRI (5)MRI 2006

03-087.indb

2008. APR. Vol. 64 For a Better Life 4 2 April 2008 April 2008 3 4 April 2008 April 2008 5 6 April 2008 April 2008 7 8 April 2008 April 2008 9 10 April 2008 April 2008 11 12 April 2008 April 2008 13 14

레이아웃 1

(47606) 100013 TEL 051.668.7900 FAX 051.668.7926 1577-7716 www.bfia.or.kr 1. 07 2. 07 3. 07 1. 10 2. 11 3. 11 1. 34 2. 44 1 44 2 47 3 51 4 54 3. 60 1 60 2 62 4. 64 7. 73 1 73 2 74 3 75 4 77 8. 79 1 79

Aesculap eurosurery YASARGIL Aneurysm Clip System G. Yasaril Dianne C.H. Yasaril Professor YasarilGuest Book 2 1 1968 CriMo 1812-1/2 2 FD 1970 CriMo 18143-1 1/2 3 FE 1983 PHYOX- ISO 5832-7 1 1/2 4 FT

天草郡市医師会第139回(臨時)代議員会

A 97 2(B A2) 4(A B3) 2 95 B 104 25(A B3) 16(B A2) 9 113 201 27 20 7 208 2 1 13 3 18 4 19 3 3 2 2 13 4 17 3 18 6 26 6 30 17 18 17 17 17 17 18 ( ) 18 ( ) 18 ( ) 18 ( ) 18 ( ) ( ) ( ) ( ) ( ) ( ) 18 ( ) (

小川／小川

T pt T T T T p T T T T T p T T T T T T p p T T T p p T p B T T T T T pt T Tp T p T T psp T p T p T p T p T p Tp T p T p T T p T T T T T T T Tp T p p p T T T T p T T T T T T T p T T T T T p p T T T T T

Cover.pdf

System6000 - 概要 搭載アルゴリズム System6000 - 使用例 簡易セッティング オペレーション ガイド System6000 - アルゴリズム一覧 System6000 v3.60 バンク プリセット リスト System6000 - オプション プライスリスト System6000 = Reverb6000 + Mastering6000 CPU6000 Mainframe6000

賃料設定、テナント契約

2 ( ) ( ) ( )

10:3012:00 13:0014:30 14:4016:10 16:2017:50 719() 722() 723() 724() 725() 726() 729() 3 9. 2 ( ) ( ) ( ) ... 4... 5... 5... 6... 8... 9...10...12...13...13...14...15...16...16...17...17...18...20...20...21...

General Instructional ObjectiveGIO Specific Behavioral ObjectivesSBOs (1) (2)

General Instructional ObjectiveGIO Specific Behavioral ObjectivesSBOs (1) (2) (3) (4) (Standard Precautions ) (5) ( ) (6) (7) ( ) ( ) QOL(Quality of Life) ( ) (8) 1 2 (1) (2) (3) 4 24 (4) 3 ABC3 (common

untitled

StoreManager 1. StoreManager POS...3 2. CSV...4 3. CSV Step1...4 4. CSV Step2...5 5. POS Step1...5 6. POS Step1...6 1....8 2....8 3....9 4....9 1. ABC... 10 2.... 10 3.... 11 4.... 11 5. ABC... 12 6....

H1＿4.ai

BEQNews Better quality of life through better nutrition 10 2010 No. Topics KUNIHIRO YAMAGATA 01 Topics 02 Interview 03 TAKESHI KUROSE Interview 04 Trend KAZUHIKO FUKATSU 05 Trend 06 Column YOSHIFUMI INOUE

星医会51号.indb

1 , / / / / / / / / / / / / / / / / / /,, / / / /// /// / / / / / / / // / CBT / / / / / / 2 / / / / / /. / / / / / / / / POS / / / / / / / / /,,, CBT 3 / / / / / / / / 4 5 ARDS ? 6 CT MRI PET/CT 7 8 MESS

統合報告書2018：財務セクション

の の 事業 事業概況 財 セ シ ン 財務セクション 1 年間の主要財務データ 85 財務分析事業環境営業概況セグメント別概況キャッシュ フローの状況設備投資等の概要研究開発財政状態配当政策 今期 ( 219 年 3 月期 ) の見通し 87 87 87 88 9 91 91 92 93 94 連結財務諸表連結財政状態計算書連結損益計算書連結包括利益計算書連結持分変動計算書連結キャッシュ フロー計算書

untitled

32 TEL: 0959-52-3000 FAX: 0959-52-4467 Email: nkh@orange.ocn.ne.jp URL: http://www.kamigoto-hospital.jp/ 1 73 MRI IT IVR PTCA 74 MC CT) NECMega-Ork 75 Web HTLV-IATL 2 ICU Holter MD-C T MRIX DSAFCR 3 4

-2-

Super Lizer HT-2200 m m W Super Lizer -1- -2- -3- -4- stellate ganglion block stellate ganglion -5- -6- -7- -8- IgA -9- " " -10- -11- 5 6 10 1-12- -1- -2- mv -3- -4- -5- -1- : -2- No.2576 P.25 1973-3-

- 1 -

19 21 - 1 - - 2 - - 3 - - 4 - 19 21 21 2224-5 - 19 2007 21 2009 H18 H27 18 27 10 H18 H22 18 22 22 H19 H21 19 21 21-6 - 20 21 19 2,449,254 2,495,506 1.9% 2,603,427 4.3% 1,593,428 1,582,704 0.7% 1,552,160

S kgikko kg T kgkg kg kg K kgkg M kgkg T kgkg F kgkg T kgkg H kgkg M kgkg 1295.893.6 kg kgkg

橡アロマセラピー症状別処方例.PDF

1 1 92 E 100ml 1 2 2 1 93 0.5m 10ml 100ml 1 2 3 2 52 0. l 2 4 3 27 3 1 1 3 3 4 5 3 2g 2 3 1 1 1 10ml 3 4 6 3 29 2 2 2 10ml 3 3 4 7 3 30 2 1 2 10ml 3 3 4 8 3 31 1 1 1 1 3 60 10 10 3 2 4 10ml A 2 3 61 20

science

science IT PERSON TO PERSON EU IT IT WHO TV I T Harvard University Brigham and Women s Hospital, Renal Division UCSF CT MRI IT 1 40 17 3 27 Winslow 1949 Impact Factor 50 1 16 1 NIH Samuel W. Cushman

...... 3... 3... 3... 4... 5... 6...... 3... 7... 35... 44... 45... 6... 68... 74... 84... 85... 87... 9... 97... 98......... 3... 6... 7... 6 3 4 5 4 69 4. 97 3.6 74 8. 7 7.3% 74 8.% 69 4.% 97 3.6%

untitled

2003 300 2015 500 2015 2006 quality of lifeqol 2012 2016 5 research guideline training practice 4 QOL QOL 2013 3 7 1 8 2 8 1 22 23 2 3 3 47 1 2 3 4. 49 1 50 2 51 1 2 3 4 3 73 1 2 3 4 5 87 1 88 2 88 1 2